Detalles de la búsqueda
1.
The Combination of Sinusoidal Perfusion Enhancement and Apoptosis Inhibition by Riociguat Plus a Galactose-PEGylated Bilirubin Multiplexing Nanomedicine Ameliorates Liver Fibrosis Progression.
Nano Lett
; 23(10): 4126-4135, 2023 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37155569
2.
Construction and validation of a bladder cancer risk model based on autophagy-related genes.
Funct Integr Genomics
; 23(1): 46, 2023 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36689018
3.
Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
Funct Integr Genomics
; 23(3): 211, 2023 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37358720
4.
Low-dose hexavalent chromium(VI) exposure promotes prostate cancer cell proliferation by activating MAGEB2-AR signal pathway.
Ecotoxicol Environ Saf
; 241: 113724, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35660381
5.
Neural precursor cell expressed, developmentally downregulated 8 promotes tumor progression and predicts poor prognosis of patients with bladder cancer.
Cancer Sci
; 110(1): 458-467, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30407690
6.
RAB38 promotes bladder cancer growth by promoting cell proliferation and motility.
World J Urol
; 37(9): 1889-1897, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30535713
7.
The comparison of perioperative outcomes of robot-assisted and open partial nephrectomy: a systematic review and meta-analysis.
World J Surg Oncol
; 14(1): 220, 2016 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27549155
8.
Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer.
Biochem Biophys Res Commun
; 468(4): 666-70, 2015 Dec 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-26551459
9.
The prognostic values and immune characteristics of polo-like kinases (PLKs) family: A pan-cancer multi-omics analysis.
Heliyon
; 10(7): e28048, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38560150
10.
Phase 2 Study of Preoperative Tislelizumab in Combination with Low-dose Nab-Paclitaxel in Patients with Muscle-invasive Bladder Cancer.
Eur Urol Oncol
; 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38762368
11.
SPP1 mRNA determination based on molecular beacon for the recurrence prognosis of bladder cancer.
Transl Androl Urol
; 12(12): 1834-1844, 2023 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38196702
12.
Construction and validation of a metabolism-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer.
BMC Med Genomics
; 16(1): 264, 2023 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37880682
13.
Comprehensive characterization of endoplasmic reticulum stress in bladder cancer revealing the association with tumor immune microenvironment and prognosis.
Front Genet
; 14: 1097179, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37091788
14.
Enhancing urinary tract infection diagnosis for negative culture patients with metagenomic next-generation sequencing (mNGS).
Front Cell Infect Microbiol
; 13: 1119020, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36936777
15.
Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data.
Heliyon
; 9(6): e16897, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37346342
16.
Withdrawal notice to: "Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data" [Heliyon 9, (2023) 16897].
Heliyon
; 9(6): e17229, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37484247
17.
Construction of an Epithelial-Mesenchymal Transition-Related Model for Clear Cell Renal Cell Carcinoma Prognosis Prediction.
Dis Markers
; 2022: 3780391, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35983409
18.
Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer.
Front Oncol
; 12: 1018285, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36300085
19.
Reducing Postoperative Recurrence of Early-Stage Hepatocellular Carcinoma by a Wound-Targeted Nanodrug.
Adv Sci (Weinh)
; 9(20): e2200477, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35524631
20.
Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence.
Biomaterials
; 281: 121362, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34998170